Cargando…

Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians

Benefits and risks of SGLT2 inhibitor use.[Image: see text]

Detalles Bibliográficos
Autores principales: Fujita, Yoshihito, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825932/
https://www.ncbi.nlm.nih.gov/pubmed/31541588
http://dx.doi.org/10.1111/jdi.13150